FDA Investigator Kumar G Janoria

Kumar G Janoria has conducted inspections on 5 sites in 4 countries as of 09 Sep 2019. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
5
Last Inspection Date:
09 Sep 2019
Investigator Role:
FDA Investigator
Redica ID:
100008035
Countries of Inspections:
China, Germany, India, United Kingdom of Great Britain and Northern Ireland
FDA Investigators that have inspected at least one site in common with Kumar G Janoria:
Alice S Tsao, Anastasia M Shields, Arsen Karapetyan, Barbara M Frazier, Bruce H Mccullough, Caryn M Mcnab, Christina Capacci Daniel, PhD, Concepcion Cruz, Jr, Cynthia Jim, CSO, Dennis Cantellops Paite, Dr. Robert C Horan, MD, Dr. Zhihao Qiu (Peter), PhD, Edwin Melendez, Emilie E Kahn, Felix Maldonado, Francis A Guidry, Guerlain Ulysse, James L Dunnie, Jr, Jennifer M Gogley, Joan A Loreng, Jose Acruz Gonzalez, June P Page, Junho Pak, Justin A Boyd, Kevin A Gonzalez, Kham Phommachanh, Laurimer Kuilan Torres, LCDR Chad N Thompson, Linda F Murphy, Lindsey M Schwierjohann, Luis A Dasta, Luis Mburgos Medero, Margaret M Annes, Marijo B Kambere, PhD, Marshalette O Edwards, Matthew A Spataro, Maya M Davis, Melissa D Ray, Michael A Charles, Mihaly S Ligmond, Mra Mcculloughj, Mra Munizn, Nancy L Rolli, Nicholas A Violand, Parul M Patel, Philip F Istafanos, DMV, MS, Roger F Zabinski, Saleem A Akhtar, Samantha J Bradley, Sandra A Hughes, Santiago Gallardo Johnson, Santos E Camara, Sixto M Mercado Rios, Stephanie A Slater, MS, Susan M Jackson, Susan T Hadman, Ted L Anderson, Terri L Dodds, Thuy T Nguyen, LCDR, Vilmary Negron Rodriguez, Virginia Carroll, PhD, Wayne E Seifert, Xiaohui Shen, Yvins Dezan, Zachary A Bogorad, Zhong Li, PhD

Kumar G Janoria's Documents

Publish Date Document Type Title
September, 2019 FDA 483 Glaxo Operations UK Ltd - Form 483, 2019-09-17
August, 2018 FDA 483 Excella GmbH & Co. KG - Form 483, 2018-08-10
February, 2017 FDA 483 MSN LABORATORIES PRIVATE LIMITED - Form 483, 2017-02-03

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more